pCDNA5-TEX264-deltaLRR-cSSH
(Plasmid
#220210)
-
PurposeMammalian expression of TEX264, 2-25 residues (LRR) truncated, C-terminal twin-Strep_HA tag
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 220210 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCDNA5/FRT/TO
-
Backbone manufacturerThermofisher
- Backbone size w/o insert (bp) 5251
-
Vector typeMammalian Expression
-
Selectable markersHygromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameTEX264
-
Alt nameZSIG11
-
SpeciesH. sapiens (human)
-
Insert Size (bp)867
-
Mutationc.4-75del / p.2-24del
-
Entrez GeneTEX264 (a.k.a. ZSIG11)
- Promoter CMV/TetO
-
Tag
/ Fusion Protein
- Strep-strep-HA (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI (not destroyed)
- 3′ cloning site NotI (not destroyed)
- 5′ sequencing primer CMVF_pCDNA3; pCMV_Fw
- 3′ sequencing primer BGH_Rev (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCDNA5-TEX264-deltaLRR-cSSH was a gift from Kristijan Ramadan (Addgene plasmid # 220210 ; http://n2t.net/addgene:220210 ; RRID:Addgene_220210) -
For your References section:
TEX264 coordinates p97- and SPRTN-mediated resolution of topoisomerase 1-DNA adducts. Fielden J, Wiseman K, Torrecilla I, Li S, Hume S, Chiang SC, Ruggiano A, Narayan Singh A, Freire R, Hassanieh S, Domingo E, Vendrell I, Fischer R, Kessler BM, Maughan TS, El-Khamisy SF, Ramadan K. Nat Commun. 2020 Mar 9;11(1):1274. doi: 10.1038/s41467-020-15000-w. 10.1038/s41467-020-15000-w PubMed 32152270